Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Counsels Incline on Close of Fund VI with More Than $1.9 Billion in CommitmentsRead MoreFacebookX.comPinterestLinkedinEmail873170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises Norwest Equity Partners on Separation from Wells FargoRead MoreFacebookX.comPinterestLinkedinEmail857170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises KKR as Part of Investor Consortium Acquiring GreenSky from Goldman SachsRead MoreFacebookX.comPinterestLinkedinEmail865170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises Vestar Capital and Edward Don on Sale of Distributor to SyscoRead MoreFacebookX.comPinterestLinkedinEmail879170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Represents Birkenstock and L Catterton on IPORead MoreFacebookX.comPinterestLinkedinEmail874170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Represented Revelstoke Capital Partners on its Minority Investment from Bonaccord Capital PartnersRead MoreFacebookX.comPinterestLinkedinEmail865170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises Warburg Pincus on $17.3 Billion Global Private Equity FundRead MoreFacebookX.comPinterestLinkedinEmail856170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises Grafine Partners on Commitment from CAZ InvestmentsRead MoreFacebookX.comPinterestLinkedinEmail870170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoCarey Olsen advises Appian Capital Advisory on closing of third mining fund at US$2.06 billionRead MoreFacebookX.comPinterestLinkedinEmail861170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 years agoKirkland Advises Bristol Myers Squibb on Acquisition of Mirati Therapeutics for up to $5.8 BillionRead MoreFacebookX.comPinterestLinkedinEmail861170
